Parker Laboratories — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Parker Laboratories is a long-established, privately-held leader in the niche but critical market of ultrasound consumables and related infection control products. The company has built a dominant global position over six decades through a focus on scientific excellence, stringent manufacturing standards (ISO 13485:2016 certified), and a comprehensive portfolio of trusted medical gels and disinfectants. Its strategy involves influencing clinical guidelines, expanding its global footprint, and innovating within the disinfection segment to address growing concerns over healthcare-associated infections. Parker operates as a stable, revenue-generating commercial entity within the broader medical device and drug delivery sectors.

Drug DeliveryMedical Devices

Technology Platform

Proprietary formulation science for medical ultrasound gels, lotions, and specialized high-level disinfectants and cleaners for medical device reprocessing.

Opportunities

Significant growth is driven by the expanding global ultrasound market and, more critically, the heightened focus on infection prevention.

Stricter guidelines for probe disinfection create a sustained demand for Parker's specialized high-level disinfectants and cleaners.

Geographic expansion into developing healthcare markets presents further opportunity for core product penetration.

Risk Factors

Key risks include competition from lower-cost generic gel manufacturers leading to price pressure, and the ongoing challenge of navigating complex, evolving regulatory environments for both medical devices and EPA-registered disinfectants.

Supply chain disruptions for raw materials could also impact costs and manufacturing.

Competitive Landscape

Parker is the acknowledged global market leader in ultrasound gels, but faces competition from other medical consumable companies (e.g., Ecolab, Sonotech) and generic manufacturers. In the disinfection segment, it competes with large, diversified infection prevention companies (e.g., PDI, Clorox Healthcare) as well as specialized probe reprocessing system vendors. Its competitive edge is its brand reputation, deep ultrasound-specific expertise, and focus on shaping clinical guidelines.

More companies in Diagnostics & Precision Medicine →More companies in United States →